Back

Alzheimer’s biomarker market projected to reach $4.7 billion by 2034

Verifying
  • DelveInsight assessed the global Alzheimer’s disease biomarker market through 2034.
  • $2.2 billion in 2025 is projected to reach $4.7 billion by 2034.
  • North America held the largest regional share, while Asia-Pacific is projected to grow fastest.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.